PRINCIPLE is a UK-wide clinical study from the University of Oxford to find COVID-19 treatments for recovery at home.
We are looking for medicines that can help people with COVID-19 symptoms get better quickly and stop them needing to go to hospital.
This international clinical trial aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19
Early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and reduced time to recovery after early COVID-19.
The TOGETHER Trial hopes to help identify which repurposed therapies are most effective, in order to slow the pandemic while many countries await the delivery of vaccines.
There are thousands of clinical trials investigating treatments and preventative measures for COVID-19. Researchers around the world are working at record speed to find the best ways to treat and prevent COVID-19, from investigating the possibility of repurposing existing drugs to searching for novel therapies against the virus.
Clinical study has been helped by a simple design, a centralized health care system, and lots of infections
The trial was up and running within six weeks of funding and found one of the world’s first COVID-19 treatments, dexamethasone. This cheap, readily available steroid was shown to reduce deaths of hospitalised COVID-19 patients by one third.
Medical researchers are beginning to shift their focus away from COVID-19 — but the pandemic could continue to affect studies focused on other diseases.
Peter Horby, co-lead on the RECOVERY platform trial, discusses the origins, lessons learned and future plans for one of the most informative studies of COVID-19 therapeutics.
A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine.
COVID-19 and Clinical Trials: The Medidata Perspective
TrialSiteNews was launched to drive more interest and awareness in clinical research, as well as to develop trust and facilitate engagement of researchers and the public. TrialSite started toward the end of 2018, financed solely by the founder, to create a new disruptive force in the world of biomedical research.